intraperitoneal injection of human ril-1 in a dose of 0.5 microgram daily for 5 d , or 1 microgram daily for 3 d , was capable of causing complete regression of immunogenic sa1 sarcoma growing subcutaneously in syngeneic or semisyngeneic mice .
C0086418
human
C1335621
ril